The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

NCT01664247 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec
DRUG: placebo
DRUG: liraglutide

Sponsor

Novo Nordisk A/S